Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 234Breast Neoplasms 132Neoplasms 97Prostatic Neoplasms 34Fatigue 34Obesity 24Lung Neoplasms 23Colorectal Neoplasms 22Polycystic Ovary Syndrome 17Ovarian Neoplasms 13Colonic Neoplasms 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Pancreatic Neoplasms 11Lymphoma 11Carcinoma, Non-Small-Cell Lung 11Weight Loss 10Rectal Neoplasms 10Multiple Myeloma 10Lymphedema 10Hematologic Neoplasms 10Head and Neck Neoplasms 10Leukemia 9Insulin Resistance 8Cardiotoxicity 8Brain Neoplasms 8Stomach Neoplasms 7Peripheral Nervous System Diseases 7Overweight 6Esophageal Neoplasms 6Cognitive Dysfunction 6

Interventions

veliparib 1tipifarnib 1pazopanib 1Mitozytrex 1Mitomycin 1Immunoglobulin G 1Geriatric Assessment 1Exercise 1Erlotinib Hydrochloride 1Disulfides 1Bevacizumab 1ARQ 197 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Solid Neoplasm × Exercise × Clear all
NCT03098277 2025-06-25

Movement Tracking Devices to Monitor Physical Activity in Patients Undergoing Chemotherapy

University of Southern California

Phase NA Completed
41 enrolled

Solid Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡